Is HIV Molecular Surveillance Worth the Risk?
This webinar reviews the scientific and public health implications of HIV molecular surveillance, hear one state public health official's perspective of how this could play out in practice, and discuss how this technology fits in with ongoing HIV criminalization advocacy. Panelists include:
- Jacob Schneider, Staff Attorney, CHLP
- Andrew Gans, MPH, HIV, STD and Hepatitis Section Manager, New Mexico Department of Health
- Ronald Johnson, US People Living with HIV Caucus
Watch below or on the CHLP YouTube channel